Acute Porphyria Drug Database

J02AX01 - Flucytosine
Propably not porphyrinogenic
PNP

Rationale
Given in gram doses but probably not significantly metabolised. No data pointing to CYP affinity. Four references state non-porphyrinogenicity.
Chemical description
Antimycotic pyrimidine derivative in systemic use (infusion of 1 g x 4) in sepsis, meningitis, endocarditis etc. Excreted mainly in unchanged form by the kidneys, small amounts converted to fluorouracil. No indications of CYP-interaction. Australian list: safe. EPI-list: safe. South African list: use. French list: use.

Similar drugs
Explore alternative drugs in similar therapeutic classes J02A / J02AX or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙